Prime Medicine, Inc. Common Stock (PRME) Stock
NASDAQ · PRME
3.19
Fundamentals
Market cap
$565.90M
Price / Earnings ratio
-3.0x
Price / Sales ratio
138.9x
Price / Book ratio
14.2x
Return on assets
-0.6%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Prime Medicine, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees146
CEODr. Allan Reine M.D.
IPO DateOct 20, 2022
HeadquartersCambridge, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey D. Marrazzo M.B.A., M.P.A. | Executive Chair | 1979 |
| Dr. Allan Reine M.D. | CEO & Director | 1975 |
| Dr. Ann L. Lee Ph.D. | Chief Technical Officer | 1962 |
| Dr. Andrew Anzalone M.D., Ph.D. | Co-Founder & Head of Platform | 1987 |
| Dr. David R. Liu Ph.D. | Co-Founder & Member of Scientific Advisory Board | — |
| Ms. Svetlana Makhni | Chief Financial Officer | 1984 |
| Mr. Ryan E. Brown J.D. | Chief Legal Officer | 1979 |
| Ms. Niamh Alix | Chief Human Resources Officer | — |
| Mr. Mohammed Asmal M.D., Ph.D. | Chief Medical Officer | — |
| Dr. Matthew J. Hawryluk M.B.A., Ph.D. | Chief Business Officer | 1979 |
Fundamentals
Valuation
Market cap$565.90M
Price-to-sales ratio138.94
Price-to-book value14.22
Price-earnings ratio-3.00
Return on Equity-189.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.08
Income Statement
Average volume2,766,680
EBITDA$-180.77M
1 year high (52w)$6.94
1 year low (52w)$2.67
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



